Abstract
Abstract: The aim was to understand the prevalence of post COVID-19 (COVISHIELD) vaccination symptoms among I dose COVID-19 vaccinated adults in Puducherry through a descriptive study and analyze the association with epidemiologic factors. 100 participants were selected according to the inclusion and exclusion criteria by systematic random sampling technique. A descriptive research design was used for the study. Data was collected using symptom questionnaire among the participants at PHC Mudaliarpet, Puducherry between the age group of 19-70 years. Data analysis was done using descriptive statistics and inferential statistics. Out of the 100 samples majority, 36 (36%) of study population were in the age group of above 50 years whereas 57 (57%) were male and 48 (48%) had no co-morbidity. The overall results of the study shows that 68 (68%) had fatigue, 41 (41%) had fever, 33 (33%) ad pain at the injection site, 26 (26%) had malaise, 9 (9%) had headache, 7 (7%) had nausea and vomiting, 4 (4%) had diarrhoea and 3 (3%) had chills. The demographic variables age have shown statistically significant association with nausea and vomiting among the selected participants with chi-square value of 2 =7.941 (d.f=3) at p<0.05 level. The study concluded stating that fatigue is the most commonly prevailing post COVID-19 vaccination symptom among I dose COVID-19 vaccinated adults. Keywords: COVID-19 Vaccination, Side effects, Symptoms
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal for Research in Applied Science and Engineering Technology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.